Malignant News and Research

RSS
Computer cluster helps understand how human cells and organs work

Computer cluster helps understand how human cells and organs work

New target to stop breast cancer growth

New target to stop breast cancer growth

Identification of early ovarian cancer symptoms may have important clinical implications

Identification of early ovarian cancer symptoms may have important clinical implications

Magnetic resonance imaging better than traditional mammography for detecting the presence of breast cancer

Magnetic resonance imaging better than traditional mammography for detecting the presence of breast cancer

Advertising restrcitions on some over the counter medicines likely to be lifted

Advertising restrcitions on some over the counter medicines likely to be lifted

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

Drug Tarceva improves survival chance for patients with advanced lung cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

Understanding focal adhesion kinase (FAK) may lead to new cancer treatments

Understanding focal adhesion kinase (FAK) may lead to new cancer treatments

Tobacco-related illnesses costs Ilinois $6.7 billion annually

Tobacco-related illnesses costs Ilinois $6.7 billion annually

New target of a cancer-causing gene

New target of a cancer-causing gene

Evidence that abnormally short telomeres play a role in the early development of cancer

Evidence that abnormally short telomeres play a role in the early development of cancer

Study finds breast cancer in men is increasing though the disease remains rare

Study finds breast cancer in men is increasing though the disease remains rare

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Chromosome losses can signal an especially poor response to therapy

Chromosome losses can signal an especially poor response to therapy

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

World's first gene therapy trial aimed at preventing cancer

World's first gene therapy trial aimed at preventing cancer

Discovery of molecular switch could lead to new treatments for lymphoma and other forms of cancer

Discovery of molecular switch could lead to new treatments for lymphoma and other forms of cancer

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Australian company receives FDA orphan drug designation for product to treat malignant melanomas